SAM #75D30126Q78901

CDC Sole Source Procurement: GentleMACS Octo Dissociator with Heaters from Miltenyi Biotec

The Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD)/Influenza Division, is planning a sole source procurement for specialized laboratory equipment. - Government Buyer: - Centers for Disease Control and Prevention (CDC) - National Center for Immunization and Respiratory Diseases (NCIRD), Influenza Division - OEM and Vendor: - Miltenyi Biotec Inc (OEM and sole source) - Products/Services Requested: - GentleMACS Octo Dissociator with Heaters (1 unit) - Instrument capable of processing eight biological samples simultaneously in a closed, sterile system - Includes integrated heating units - Instrument service plan included - No part numbers specified - Unique/Notable Requirements: - Only instrument commercially available that meets CDC's requirements for: - Fully closed, sterile sample processing - Simultaneous processing of eight samples - Integrated heating and validated programmable protocols - Proprietary mechanical dissociation architecture - Compatibility with C Tubes and M Tubes consumables - Compatibility with downstream Luminex and single-cell sequencing workflows - Sole source justification under FAR 12.102(a) - Place of Performance/Delivery: - CDC, Atlanta, Georgia

Description

The Centers for Disease Control and Prevention’s National Center for Immunization and Respiratory Diseases (NCIRD)/Influenza Division (ID) intends to award a sole source firm fixed price purchase order to Miltenyi Biotec Inc, UEI # ZLDPMHA3M333, 2303 Lindbergh St, Auburn, Ca 95602, to provide 1 GentleMACS Octo Dissocciator with heating units with an instrument service plan.  Miltenyi Biotec Inc GentleMACS Octo Dissocciator with heating units is the only commercially available instrument capable of simultaneously processing eight biological samples in a fully closed, sterile system with integrated heating and validated programmable protocols that are already incorporated into the validated Standard Operating Procedures (SOPs) per the Quality Manual for Microbiological Laboratories (QMML).  The systems proprietary mechanical dissociation architecture, protected by active patents, allows for reproducible, high-viability single-cell and nuclei preparations across multiple tissue types without operator-dependent variability. It is also the only system with OEM-developed, tissue-specific programs that can be run without additional programming or third-party modification, and it supports the required consumable formats (C Tubes and M Tubes) that maintain sterility and traceability. No other system combines these capabilities with proven compatibility for downstream Luminex and single-cell sequencing workflows under current quality and regulatory requirements. This contract action is for a commercial supply for which the Government intends to solicit and negotiate with only one source under the authority of FAR 12.102(a).

This notice of intent is not a request for competitive quotations; however, all quotations/responses received within 15 days of the issuance of this notice will be considered by the government.  A determination by the government not to complete this proposed purchase order based upon responses to this notice is solely within the discretion of the government.  Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement.  Any quotation/response should be emailed to the contract specialist at email zvm0@cdc.gov by 04/07/2026.

View original listing